Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Neugrin, neurite outgrowth associated (NGRN) is a mitochondrial-associated protein involved in the biogenesis and assembly of mitochondrial ribosomes[1][3][4][5][6]. It acts as a component of a multi-protein/RNA module—alongside proteins such as RCC1L, RPUSD3, RPUSD4, TRUB2, FASTKD2, and 16S mitochondrial ribosomal RNA—regulating the abundance of 16S mt-rRNA and required for intra-mitochondrial translation of core subunits essential for mitochondrial oxidative phosphorylation[1][3][4][5]. NGRN displays rRNA binding activity, positively influences mitochondrial translation, and is localized to the mitochondrion, mitotic spindle, and nuclear body[4][7]. Human diseases linked to NGRN include a subset of hereditary deafness, but only limited association with broader pathophysiological processes has been reported to date[4]. NGRN is not a receptor, enzyme, transporter, or recognized direct therapeutic target, and currently there are no known drugs or clinical biomarker assays targeting this protein[4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neugrin, neurite outgrowth associated (NGRN).